Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

Prevention of Childhood Anxiety Disorders in Offspring of Anxious Parents

Lead Sponsor:

Karolinska Institutet

Conditions:

Anxiety Disorders

Eligibility:

All Genders

5-9 years

Phase:

NA

Brief Summary

This study aims to expand the evidence of prevention of anxiety disorders in children. Children of anxious parents are at increased risk of developing anxiety disorders. Twin studies support a direct ...

Detailed Description

RESEARCH QUESTIONS * Is the CPBC-program effective in preventing childhood anxiety disorders within a period of 12 and 36 months respectively, compared to a self-help parenting book? * Is the CPBC-pr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The parent suffers from exaggerated worry or anxiety
  • The parent speaks and reads Swedish
  • The child is 5-9 years old
  • The child receives a clinicians assigned clinical severity rating (CSR) of 1 to 3 on anxiety disorders in ADIS-C (subclinical symptoms of anxiety)
  • Exclusion criteria:
  • Current or recent parental alcohol or substance abuse
  • The parent suffer from severe psychiatric conditions (e.g.current or recent psychotic or manic/hypomanic symptoms, severe depression or increased risk of suicide)
  • Social conditions that would obstruct from participation (e.g.ongoing custody dispute, domestic violence, ongoing investigation of child neglect through social services)
  • The child suffers from/is currently in treatment for an anxiety disorder or depression
  • The child is currently undergoing a neuropsychological evaluation
  • The child has no symptoms of anxiety at all (the child receives a clinicians assigned CSR of 0 on all anxiety disorders in the ADIS-C interview )
  • The child meet criteria for an anxiety disorder (the child receives a clinicians assigned CSR of 4 or above on any anxiety disorder in ADIS-C interview )

Exclusion

    Key Trial Info

    Start Date :

    February 15 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2025

    Estimated Enrollment :

    215 Patients enrolled

    Trial Details

    Trial ID

    NCT04722731

    Start Date

    February 15 2021

    End Date

    July 1 2025

    Last Update

    October 4 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Karolinska Institutet

    Solna, Sweden, 171 65